January 14, 2015 – The tranSMART Foundation, a non-profit organization providing a global, open-source knowledge management platform for scientists to share pre-competitive translational research data, today announced that 20 life sciences and technology organizations have made substantial commitments by joining its Membership Program. Members not only become integral parts of the Foundation’s community, they also provide the financial support necessary to sustain the organization and continually enhance the tranSMART open-source platform.
The benefits of membership include participation in sustaining the tranSMART open-source community, the opportunity to serve on the board of directors and membership on the 3C operating committees (Code, Content and Community). The work of the Foundation is directed by the board and carried out by the 3C Committees, their component Working Groups and the Foundation management team.
“Since launching the Membership Program one year ago, we have had tremendous support from pharmaceutical, biotech and technology companies, as well as academic institutions who have become engaged in our efforts,” said tranSMART Foundation CEO Keith Elliston, PhD. “These organizations realize the value that the tranSMART open-source platform can offer to the advancement of translational medicine research, and the role of the tranSMART Foundation in catalyzing this community. We appreciate the dedication and support of all of our members, who have helped us mobilize the community to produce two new versions of the platform over the past 18 months, and we look forward to their continued contributions to propel this initiative forward.”
The tranSMART Foundation is launching a new membership campaign for 2015. During this time, it will encourage each of its current members to renew their memberships, and will bring new members to the Foundation at both the Gold and Silver levels.
ConvergeHEALTH by Deloitte, Oracle, PerkinElmer, Pfizer, Roche, Sanofi, and Takeda have all joined at the Gold Level, which includes a minimum investment of $100,000 per year to fund the Foundation. Additionally, John’s Hopkins University and the University of Michigan have joined as academic Gold members. At this level, these organizations can elect a representative from their company to the tranSMART board of directors and have a representative on all three of the Foundation’s 3C operating committees, focusing on Code, Community and Content.
Silver-level members include: ARLION; AssureRx; Cognizant; Institute for Systems Biology; One Mind; Saama Technologies, Inc.; and the Hyve. Each of the Silver members makes a minimum investment of $5,000 to $20,000 to help fund the Foundation’s operations. Silver members have the opportunity to submit a representative to a pool of candidates to be elected the Foundation’s board, and can nominate one individual to one of the Foundation’s 3C’s committees.
The Foundation also has an Affiliate program, whose members provide sponsorship and support for its activities. The Affiliate members include: BT-GS, Elevada, Harvard University, and Rancho Biosciences.
About The tranSMART Foundation
The tranSMART Foundation is a non-profit organization that provides an open-source, cloud-based, data-sharing and analysis platform that enables scientists at universities, disease foundations, pharmaceutical companies, and government agencies around the world to share pre-competitive data in a way that saves money and time in translating research findings into new therapies and diagnostic tools. Founded to steward the tranSMART platform, the Foundation is headquartered in Wakefield, Massachusetts with Centers of Excellence in Ann Arbor, Mich.; London, England; Boston, Mass.; and Amsterdam, Netherlands. The tranSMART Foundation can also be found on the web at www.tranSMARTFoundation.org.